MicroRNA biomarkers in lung cancer: MiRacle or quagMiRe?

Sai Yendamuri, Robert Kratzke

Research output: Contribution to journalReview articlepeer-review

22 Scopus citations


MicroRNAs have emerged as novel and important regulators of translation. Besides their biological significance, they are being investigated as potential biomarkers of physiological and pathological states. This review article summarizes current investigations of microRNAs as biomarkers in lung cancer. The promises and pitfalls of this exciting new investigational avenue are highlighted.

Original languageEnglish (US)
Pages (from-to)209-215
Number of pages7
JournalTranslational Research
Issue number4
StatePublished - Apr 2011

Bibliographical note

Funding Information:
Supported by research grants from the Buswell Foundation and the Thoracic Surgery Foundation for Research and Education , and by a Young Investigator Award from the Cancer and Leukemia Group B (CALGB) Foundation. Research support was also received from the Medical Prognosis Institute , Horsholm, Denmark.

Copyright 2018 Elsevier B.V., All rights reserved.


  • CT
  • FFPE
  • RBC
  • RT-PCR
  • computed tomography
  • formalin-fixed paraffin-embedded
  • real-time polymerase chain reaction
  • red blood cell


Dive into the research topics of 'MicroRNA biomarkers in lung cancer: MiRacle or quagMiRe?'. Together they form a unique fingerprint.

Cite this